Northwest Biotherapeutics (NWBO) Net Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Northwest Biotherapeutics (NWBO) Net Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -392.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,636.00 |
| 10 | Northwest Biotherapeutics | 278.23 Mn | 277.63 Mn | - | 1.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.10 Mn |
| Mar 31, 2026 | 454,054.00 |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | -812,713.00 |
| Jun 30, 2025 | -857,622.00 |
| Mar 31, 2025 | 141,909.00 |
| Dec 31, 2024 | -911,840.00 |
| Sep 30, 2024 | 45,756.00 |
| Jun 30, 2024 | 385,607.00 |
| Mar 31, 2024 | -539,255.00 |
| Dec 31, 2023 | 152,251.00 |
| Sep 30, 2023 | 1.00 Mn |
| Jun 30, 2023 | -122,656.00 |
| Mar 31, 2023 | 227,171.00 |
| Sep 30, 2022 | -1.72 Mn |
| Jun 30, 2022 | -727,980.00 |
| Mar 31, 2022 | -180,194.00 |
| Sep 30, 2021 | 9.11 Mn |
| Jun 30, 2021 | 290.37 Mn |
| Mar 31, 2021 | -218,581.00 |